WellPoint (WLP), the largest health benefits company in the U.S., grew even larger last week with the completion of its purchase of WellChoice. The closing of the $6.5-billion deal, which was announced last September, makes shares of the managed-care giant even more attractive for the coming year, says Standard Poor's analyst Phillip Seligman.
Seligman, who already liked the long-term earnings prospects for the company, reiterated his "strong buy" recommendation for the stock following the announcement on December 28. The stock is highlighted in the January 4 issue of SP's Outlook newsletter.
WellPoint, which itself was formed by a merger between Anthem and WellPoint Health Networks in late 2004, serves 34 million medical members, including the 5 million it has gained from WellChoice. It provides health insurance under the Blue Cross/Blue Shield brand in several states. That well-known name is an advantage for attracting new members, Seligman says, considering its "long-standing reputation for high quality service."
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
WellChoice was the last remaining publicly traded Blue licensee, besides WellPoint. Its strong presence in the Northeast should be a boon for WellPoint's national accounts business, Seligman says.
WellPoint competes against such companies as UnitedHealth Group and Aetna. SP gives all three stocks its highest five-star rating.
Seligman says the purchase likely won't affect WellPoint's earnings this year. However, he sees the deal adding 5 cents a share to the company's 2007 profits, which he now estimates at $5.35 per share.
The stock made strong gains in 2005, climbing 39% for the year. At $79, the stock trades at 17 times the 2006 consensus earnings estimate of $4.58 per share. Analysts expect earnings to grow 15% annually over the next five years.
--Lisa Dixon
-
Stocks Retreat as Bubble Worries Ramp Up: Stock Market TodayValuation concerns took hold on Wall Street today, sending Palantir and its fellow tech stocks lower.
-
The Best Mid-Cap ETFs to BuyThe best mid-cap ETFs to buy offer efficient and diversified exposure to a universe full of highly interesting companies.
-
If You'd Put $1,000 Into Home Depot Stock 20 Years Ago, Here's What You'd Have TodayHome Depot stock has been a buy-and-hold banger for truly long-term investors.
-
What the Rich Know About Investing That You Don'tPeople like Warren Buffett become people like Warren Buffett by following basic rules and being disciplined. Here's how to accumulate real wealth.
-
If You'd Put $1,000 Into Bank of America Stock 20 Years Ago, Here's What You'd Have TodayBank of America stock has been a massive buy-and-hold bust.
-
If You'd Put $1,000 Into Oracle Stock 20 Years Ago, Here's What You'd Have TodayORCL Oracle stock has been an outstanding buy-and-hold bet for decades.
-
How to Invest for Rising Data Integrity RiskAmid a broad assault on venerable institutions, President Trump has targeted agencies responsible for data critical to markets. How should investors respond?
-
If You'd Put $1,000 Into Sherwin-Williams Stock 20 Years Ago, Here's What You'd Have TodaySherwin-Williams stock has clobbered the broader market by a wide margin for a long time.
-
If You'd Put $1,000 Into UnitedHealth Group Stock 20 Years Ago, Here's What You'd Have TodayUNH stock was a massive market beater for ages — until it wasn't.
-
What Tariffs Mean for Your Sector ExposureNew, higher and changing tariffs will ripple through the economy and into share prices for many quarters to come.
